Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
June 20, 2020
Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer
Daniel C Liebler, Timothy R Holzer, Alexander Haragan, et al.
Investigational New Drugs
|
February 6, 2017
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
Patricia M LoRusso, Mrinal Gounder, Shadia I Jalal, et al.
Journal of Translational Medicine
|
March 19, 2022
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab
Jonathan T Sims, Josh Poorbaugh, Ching-Yun Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer
David S Hong, Razelle Kurzrock, Yun Oh, et al.
Journal of Neuropathology and Experimental Neurology
|
September 19, 2025
Convolutional neural network-derived neurofibrillary tangle classifiers: Investigative tools to identify maturation levels and explore post-translational modifications using laser capture microdissection coupled mass spectrometry
Couger Jimenez Jaramillo, Drew Nedderman, Erpan Ahat, et al.
Archives of Pathology & Laboratory Medicine
|
July 7, 2021
Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization
Jessica A Baker, Anthony N Sireci, Narasimha Marella, et al.
Plos One
|
November 19, 2013
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung
Timothy R Holzer, Angie D Fulford, Drew M Nedderman, et al.
JAMA
|
January 21, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Robert L Gottlieb, Ajay Nirula, Peter Chen, et al.
Histopathology
|
July 22, 2014
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)
Aaron M Gruver, Ling Liu, Peter Vaillancourt, et al.
The New England Journal of Medicine
|
July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
June 20, 2020
Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer
Daniel C Liebler, Timothy R Holzer, Alexander Haragan, et al.
Investigational New Drugs
|
February 6, 2017
Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors
Patricia M LoRusso, Mrinal Gounder, Shadia I Jalal, et al.
Journal of Translational Medicine
|
March 19, 2022
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab
Jonathan T Sims, Josh Poorbaugh, Ching-Yun Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer
David S Hong, Razelle Kurzrock, Yun Oh, et al.
Journal of Neuropathology and Experimental Neurology
|
September 19, 2025
Convolutional neural network-derived neurofibrillary tangle classifiers: Investigative tools to identify maturation levels and explore post-translational modifications using laser capture microdissection coupled mass spectrometry
Couger Jimenez Jaramillo, Drew Nedderman, Erpan Ahat, et al.
Archives of Pathology & Laboratory Medicine
|
July 7, 2021
Analytical Accuracy of RET Fusion Detection by Break-Apart Fluorescence In Situ Hybridization
Jessica A Baker, Anthony N Sireci, Narasimha Marella, et al.
Plos One
|
November 19, 2013
Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung
Timothy R Holzer, Angie D Fulford, Drew M Nedderman, et al.
JAMA
|
January 21, 2021
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
Robert L Gottlieb, Ajay Nirula, Peter Chen, et al.
Histopathology
|
July 22, 2014
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET)
Aaron M Gruver, Ling Liu, Peter Vaillancourt, et al.
The New England Journal of Medicine
|
July 14, 2021
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Michael Dougan, Ajay Nirula, Masoud Azizad, et al.
Page
of 3